Harith Rajagopalan - 01 Feb 2024 Form 3 Insider Report for Fractyl Health, Inc. (GUTS)

Role
Chief Executive Officer, Director
Signature
/s/ Lisa A. Davidson, Attorney-in-fact
Issuer symbol
GUTS
Transactions as of
01 Feb 2024
Net transactions value
$0
Form type
3
Filing time
01 Feb 2024, 18:18:20 UTC
Next filing
08 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GUTS Common Stock 656,570 01 Feb 2024 Direct
holding GUTS Common Stock 289,375 01 Feb 2024 By 2016 Irrevocable Trust
holding GUTS Common Stock 18,639 01 Feb 2024 By 2021 Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GUTS Series A Preferred Stock 01 Feb 2024 Common Stock 6,523 Direct F1
holding GUTS Series A Preferred Stock 01 Feb 2024 Common Stock 2,795 By 2016 Irrevocable Trust F1
holding GUTS Stock Option 01 Feb 2024 Common Stock 190,968 $1.70 Direct F2
holding GUTS Stock Option 01 Feb 2024 Common Stock 123,484 $1.70 Direct F2
holding GUTS Stock Option 01 Feb 2024 Common Stock 345,078 $2.67 Direct F2
holding GUTS Stock Option 01 Feb 2024 Common Stock 179,868 $2.67 Direct F2
holding GUTS Stock Option 01 Feb 2024 Common Stock 422,473 $3.35 Direct F2
holding GUTS Stock Option 01 Feb 2024 Common Stock 475,021 $3.89 Direct F3
holding GUTS Stock Option 01 Feb 2024 Common Stock 262,937 $6.98 Direct F4
holding GUTS Stock Option 01 Feb 2024 Common Stock 16,309 $8.59 Direct F5
holding GUTS Stock Option 01 Feb 2024 Common Stock 32,618 $8.18 Direct F6
holding GUTS Stock Option 01 Feb 2024 Common Stock 17,031 $11.21 Direct F7
holding GUTS Restricted Stock Units 01 Feb 2024 Common Stock 216,924 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election in accordance with the terms of such preferred stock and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering.
F2 The stock option is fully vested and currently exercisable.
F3 The stock option vests in 48 monthly installments beginning on April 26, 2020.
F4 The stock option vests in 48 monthly installments beginning on July 24, 2021.
F5 The stock option vests in 48 monthly installments beginning on October 7, 2022.
F6 The stock option vests in 48 monthly installments beginning on April 16, 2023.
F7 The stock option vests in 48 monthly installments beginning on December 10, 2023.
F8 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest on November 10, 2024 and have no expiration date.

Remarks:

Exhibit 24 - Power of Attorney.